Skip to content

Clinical trials

Retinoblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinoblastoma Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20031
20052
20063
20072
20082
20093
20104
20114
20122
20132
20142
20151
20161
20172
20183
20193
20202
20211
20222
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting10
Terminated9
Active, not recruiting5
Withdrawn3
Unknown status2
No longer available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center10
St. Jude Children's Research Hospital9
Children's Oncology Group5
National Cancer Institute (NCI)5
Masonic Cancer Center, University of Minnesota3
Children's Hospital Medical Center, Cincinnati2
Emory University2
Seattle Children's Hospital2
Stanford University2
Targeted Therapy Technologies, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinoblastoma62
Neuroblastoma25
Sarcoma21
Medulloblastoma17
Osteosarcoma17
Wilms Tumor16
Rhabdomyosarcoma15
Central Nervous System Neoplasms12
Sarcoma, Ewing11
Astrocytoma10

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.